BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25075743)

  • 21. Outcomes among HIV-infected children initiating HIV care and antiretroviral treatment in Ethiopia.
    Melaku Z; Lulseged S; Wang C; Lamb MR; Gutema Y; Teasdale CA; Ahmed S; Gadisa T; Habtamu Z; Bedri A; Fayorsey R; Abrams EJ
    Trop Med Int Health; 2017 Apr; 22(4):474-484. PubMed ID: 28066962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
    Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
    PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes Among Children Enrolled in HIV Care in Mozambique 2009-2013.
    Teasdale CA; Yang J; Thome B; Yersin I; Sebastian T; Brusamento S; Lahuerta M; Jobarteh KM; Abrams EJ
    Pediatr Infect Dis J; 2016 Oct; 35(10):1117-25. PubMed ID: 27622685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.
    Geng EH; Hunt PW; Diero LO; Kimaiyo S; Somi GR; Okong P; Bangsberg DR; Bwana MB; Cohen CR; Otieno JA; Wabwire D; Elul B; Nash D; Easterbrook PJ; Braitstein P; Musick BS; Martin JN; Yiannoutsos CT; Wools-Kaloustian K
    J Int AIDS Soc; 2011 Sep; 14():46. PubMed ID: 21955541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes after antiretroviral therapy during the expansion of HIV services in Haiti.
    McNairy ML; Joseph P; Unterbrink M; Galbaud S; Mathon JE; Rivera V; Jannat-Khah D; Reif L; Koenig SP; Domercant JW; Johnson W; Fitzgerald DW; Pape JW
    PLoS One; 2017; 12(4):e0175521. PubMed ID: 28437477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early outcomes after implementation of treat all in Rwanda: an interrupted time series study.
    Ross J; Sinayobye JD; Yotebieng M; Hoover DR; Shi Q; Ribakare M; Remera E; Bachhuber MA; Murenzi G; Sugira V; Nash D; Anastos K;
    J Int AIDS Soc; 2019 Apr; 22(4):e25279. PubMed ID: 30993854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
    Kerkhoff AD; Sikombe K; Eshun-Wilson I; Sikazwe I; Glidden DV; Pry JM; Somwe P; Beres LK; Simbeza S; Mwamba C; Bukankala C; Hantuba C; Moore CB; Holmes CB; Padian N; Geng EH
    PLoS Med; 2020 May; 17(5):e1003107. PubMed ID: 32401797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes.
    Lahuerta M; Lima J; Elul B; Okamura M; Alvim MF; Nuwagaba-Biribonwoha H; Horowitz D; Fernandes R; Assan A; Abrams EJ; El-Sadr WM; Nash D
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):e75-86. PubMed ID: 21725246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling adverse treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics in Lusaka.
    Fwemba I; Musonda P
    Public Health; 2017 Jun; 147():8-14. PubMed ID: 28404502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decentralization of pediatric HIV care and treatment in five sub-Saharan African countries.
    Fayorsey RN; Saito S; Carter RJ; Gusmao E; Frederix K; Koech-Keter E; Tene G; Panya M; Abrams EJ
    J Acquir Immune Defic Syndr; 2013 Apr; 62(5):e124-30. PubMed ID: 23337367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan Africa.
    Lamb MR; El-Sadr WM; Geng E; Nash D
    PLoS One; 2012; 7(6):e38443. PubMed ID: 22685569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.
    Lahuerta M; Wu Y; Hoffman S; Elul B; Kulkarni SG; Remien RH; Nuwagaba-Biribonwoha H; El-Sadr W; Nash D; ;
    Clin Infect Dis; 2014 Feb; 58(3):432-41. PubMed ID: 24198226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
    Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
    Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
    Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
    Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
    Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
    BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda.
    Rich ML; Miller AC; Niyigena P; Franke MF; Niyonzima JB; Socci A; Drobac PC; Hakizamungu M; Mayfield A; Ruhayisha R; Epino H; Stulac S; Cancedda C; Karamaga A; Niyonzima S; Yarbrough C; Fleming J; Amoroso C; Mukherjee J; Murray M; Farmer P; Binagwaho A
    J Acquir Immune Defic Syndr; 2012 Mar; 59(3):e35-42. PubMed ID: 22156912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
    AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme.
    Nsanzimana S; Kanters S; Remera E; Forrest JI; Binagwaho A; Condo J; Mills EJ
    Lancet HIV; 2015 May; 2(5):e208-15. PubMed ID: 26423003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.
    Koole O; Tsui S; Wabwire-Mangen F; Kwesigabo G; Menten J; Mulenga M; Auld A; Agolory S; Mukadi YD; Colebunders R; Bangsberg DR; van Praag E; Torpey K; Williams S; Kaplan J; Zee A; Denison J
    Trop Med Int Health; 2014 Dec; 19(12):1397-410. PubMed ID: 25227621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.